PROGRAM | Kisaco Research

PROGRAM

Health Equity in Clinical Trials Congress | May 8 - 9, 2024 | Atlanta
8-9 May, 2024
ATLANTA

DOWLOAD THE PROGRAM

"It was so energizing being amongst health equity thought and practice leaders from across the globe!"  

- Leigh Boehmer, Chief Medical Officer, Association of Community Cancer Centers

Our program platforms case-studies, data-driven solutions, and best practices from across the clinical trials ecosystem to innovate health equity approaches and facilitate collaborative action.

  • Receive the implementable tools to operationalize clinical trial diversity strategy and innovate the health equity lens applied in your role, at your organization
  • Network with 400+ senior executives driving forward the health equity mission and 200+ clinical trial decision-makers to center health equity in your collaboration and partnership considerations
  • Unlock new health equity approaches and optimize your initiatives as we platform all voices across the industry and delve into operational developments, network construction, data strategies, community engagement, patient trust, accessibility, and the role of technology

Wednesday, 8 May, 2024

Patient Perspectives: Progressing Health Equity and Empowering Underserved Communities

  • Patients are the quality control of health equity developments, sharing experiences of clinical trial participation, highlighting the successes of improved patient experience.
  • What can the industry learn from patient experts, discussing the implementation of patient voice into health equity strategic programs.
  • Includes an open Q&A towards the end of the panel to ask critical questions to patients and facilitate industry learning. 

Author:

Allison Kalloo

Patient Advocate & CEO
Clinical Ambassador

Allison Kalloo

Patient Advocate & CEO
Clinical Ambassador

Author:

Sabina Kineen

Rare Disease Patient, Caregiver, Advocate

Sabina Kineen

Rare Disease Patient, Caregiver, Advocate

From Competitors to Collaborators: Co-operative Pharmaceutical Developments & Health Equity Solutions

  • Platforming the tangible successes pharmaceutical companies are having to improve DEI in clinical trials.
  • Highlighting data-driven strategies to improve site capabilities for underserved-patient engagement, recruitment, and experience.
  • The importance of collaboration and standardization from a large-scale initative perspective, where are we at and where do we need to be.

Author:

Michel Reid

Global Head of Demographics & Diversity
GSK

Michel Reid

Global Head of Demographics & Diversity
GSK

Author:

Alana Miller

Associate Director, Diversity in Clinical Trials
Merck

Alana Miller

Associate Director, Diversity in Clinical Trials
Merck

Author:

Monique Adams

Executive Director, Diversity & Inclusion in Clinical Trials
Sanofi

Monique Adams

Executive Director, Diversity & Inclusion in Clinical Trials
Sanofi
Thursday, 9 May, 2024

Data Driven Solutions and Successes for Clinical Trial Diversity

  • Discussing implementation of RWE in upstream and downstream clinical operations to improve diversity strategy.
  • Platforming cases of qualitative data retrieval and how this aids understanding of under-served populations.

Author:

Mary Nwokedi

Director, Clinical Trial Diversity: Science and Regulatory Advocacy
PhRMA

Mary Nwokedi

Director, Clinical Trial Diversity: Science and Regulatory Advocacy
PhRMA

Author:

Kemi Willaims

Senior Director, Patient Science
AstraZeneca

Kemi Willaims

Senior Director, Patient Science
AstraZeneca

Centering Health Equity in Clinical Trial Design

  • How are we ensuring under-served patient populations voices are considered in trial format?
  • Optimizing both population data and clinical data analytics to develop accessible and equitable clinical trials. 

Author:

Brittany Gerald

Associate Director, Clinical Trial Diversity and Inclusion, Patient and Site Experience (PASE)
Moderna

Brittany Gerald

Associate Director, Clinical Trial Diversity and Inclusion, Patient and Site Experience (PASE)
Moderna

Author:

Benjamin Young

Senior Global Medical Director
ViiV Healthcare

Benjamin Young

Senior Global Medical Director
ViiV Healthcare

Author:

Sandra Amaro

Head of Clinical Trial Diversity
Pfizer

Sandra Amaro

Head of Clinical Trial Diversity
Pfizer

Jump to: Day 1 | Day 2

DOWNLOAD THE PROGRAM